S&P 500   3,400.97 (-1.86%)
DOW   27,685.38 (-2.29%)
QQQ   280.47 (-1.50%)
AAPL   115.05 (+0.01%)
MSFT   210.08 (-2.84%)
FB   277.11 (-2.70%)
GOOGL   1,584.29 (-2.98%)
AMZN   3,207.04 (+0.08%)
TSLA   420.28 (-0.08%)
NVDA   525.65 (-3.30%)
BABA   306.87 (-0.98%)
CGC   18.53 (-6.08%)
GE   7.38 (-3.28%)
MU   52.14 (-1.34%)
AMD   82.23 (+0.33%)
T   27.38 (-1.58%)
F   8.03 (-1.59%)
ACB   4.40 (-5.98%)
GILD   59.96 (-1.37%)
NFLX   488.24 (+-0.01%)
NIO   26.01 (-4.23%)
BA   160.83 (-3.90%)
DIS   124.06 (-3.34%)
S&P 500   3,400.97 (-1.86%)
DOW   27,685.38 (-2.29%)
QQQ   280.47 (-1.50%)
AAPL   115.05 (+0.01%)
MSFT   210.08 (-2.84%)
FB   277.11 (-2.70%)
GOOGL   1,584.29 (-2.98%)
AMZN   3,207.04 (+0.08%)
TSLA   420.28 (-0.08%)
NVDA   525.65 (-3.30%)
BABA   306.87 (-0.98%)
CGC   18.53 (-6.08%)
GE   7.38 (-3.28%)
MU   52.14 (-1.34%)
AMD   82.23 (+0.33%)
T   27.38 (-1.58%)
F   8.03 (-1.59%)
ACB   4.40 (-5.98%)
GILD   59.96 (-1.37%)
NFLX   488.24 (+-0.01%)
NIO   26.01 (-4.23%)
BA   160.83 (-3.90%)
DIS   124.06 (-3.34%)
S&P 500   3,400.97 (-1.86%)
DOW   27,685.38 (-2.29%)
QQQ   280.47 (-1.50%)
AAPL   115.05 (+0.01%)
MSFT   210.08 (-2.84%)
FB   277.11 (-2.70%)
GOOGL   1,584.29 (-2.98%)
AMZN   3,207.04 (+0.08%)
TSLA   420.28 (-0.08%)
NVDA   525.65 (-3.30%)
BABA   306.87 (-0.98%)
CGC   18.53 (-6.08%)
GE   7.38 (-3.28%)
MU   52.14 (-1.34%)
AMD   82.23 (+0.33%)
T   27.38 (-1.58%)
F   8.03 (-1.59%)
ACB   4.40 (-5.98%)
GILD   59.96 (-1.37%)
NFLX   488.24 (+-0.01%)
NIO   26.01 (-4.23%)
BA   160.83 (-3.90%)
DIS   124.06 (-3.34%)
S&P 500   3,400.97 (-1.86%)
DOW   27,685.38 (-2.29%)
QQQ   280.47 (-1.50%)
AAPL   115.05 (+0.01%)
MSFT   210.08 (-2.84%)
FB   277.11 (-2.70%)
GOOGL   1,584.29 (-2.98%)
AMZN   3,207.04 (+0.08%)
TSLA   420.28 (-0.08%)
NVDA   525.65 (-3.30%)
BABA   306.87 (-0.98%)
CGC   18.53 (-6.08%)
GE   7.38 (-3.28%)
MU   52.14 (-1.34%)
AMD   82.23 (+0.33%)
T   27.38 (-1.58%)
F   8.03 (-1.59%)
ACB   4.40 (-5.98%)
GILD   59.96 (-1.37%)
NFLX   488.24 (+-0.01%)
NIO   26.01 (-4.23%)
BA   160.83 (-3.90%)
DIS   124.06 (-3.34%)
Log in
NYSE:TDOC

Teladoc Health Stock Forecast, Price & News

$212.15
-4.17 (-1.93 %)
(As of 10/26/2020 05:12 PM ET)
Add
Compare
Today's Range
$209.00
Now: $212.15▼
$223.70
50-Day Range
$189.91
MA: $211.35▼
$231.80
52-Week Range
$67.46
Now: $212.15▼
$253.00
Volume2.21 million shs
Average Volume3.11 million shs
Market Capitalization$17.60 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.25
Teladoc Health, Inc. provides virtual healthcare services on a business-to-business basis in the United States and internationally. It covers various clinical conditions, including non-critical, episodic care, chronic, and complicated cases like cancer and congestive heart failure, as well as offers telehealth solutions, expert medical services, behavioral health solutions, guidance and support, and platform and program services. The company's platform enables patients and providers to have an integrated smart user experience through mobile, Web, and phone based accessed points. 0It serves health employers, health plans, hospitals, health systems, and insurance and financial services companies. Teladoc Health, Inc. offers its products and services under the Teladoc, Advance Medical, Best Doctors, BetterHelp, and HealthiestYou brands. Teladoc Health, Inc. has alliance with NTT DATA Services to build nucleus for healthcare. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was founded in 2002 and is headquartered in Purchase, New York.
Read More
Teladoc Health logo

Beat the Market (BTM) Rank™

Analyst Opinion: 2.3Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

1.33 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Offices & clinics of medical doctors
Sub-IndustryN/A
SectorMedical
Current SymbolNYSE:TDOC
Previous Symbol
CUSIPN/A
CIK1477449
Webwww.teladochealth.com
Phone203-635-2002
Employees2,400

Debt

Debt-to-Equity Ratio0.73
Current Ratio11.36
Quick Ratio11.36

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$553.31 million
Price / Sales31.81
Cash FlowN/A
Price / Cash FlowN/A
Book Value$14.01 per share
Price / Book15.14

Profitability

EPS (Most Recent Fiscal Year)($1.49)
Net Income$-98,860,000.00
Net Margins-13.22%
Return on Equity-9.54%
Return on Assets-5.71%

Miscellaneous

Outstanding Shares82,958,000
Market Cap$17.60 billion
Next Earnings Date10/28/2020 (Confirmed)
OptionableOptionable
$212.15
-4.17 (-1.93 %)
(As of 10/26/2020 05:12 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TDOC News and Ratings via Email

Sign-up to receive the latest news and ratings for TDOC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Teladoc Health (NYSE:TDOC) Frequently Asked Questions

How has Teladoc Health's stock been impacted by Coronavirus (COVID-19)?

Teladoc Health's stock was trading at $137.40 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, TDOC shares have increased by 54.4% and is now trading at $212.15.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of Teladoc Health?

28 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teladoc Health in the last year. There are currently 11 hold ratings and 17 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Teladoc Health.

When is Teladoc Health's next earnings date?

Teladoc Health is scheduled to release its next quarterly earnings announcement on Wednesday, October 28th 2020.
View our earnings forecast for Teladoc Health.

How can I listen to Teladoc Health's earnings call?

Teladoc Health will be holding an earnings conference call on Wednesday, October 28th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Teladoc Health's earnings last quarter?

Teladoc Health, Inc. (NYSE:TDOC) released its earnings results on Wednesday, July, 29th. The health services provider reported ($0.34) EPS for the quarter, missing the consensus estimate of ($0.23) by $0.11. The health services provider earned $241.03 million during the quarter, compared to the consensus estimate of $220.49 million. Teladoc Health had a negative return on equity of 9.54% and a negative net margin of 13.22%. Teladoc Health's revenue for the quarter was up 85.0% on a year-over-year basis. During the same period last year, the business posted ($0.41) earnings per share.
View Teladoc Health's earnings history.

What guidance has Teladoc Health issued on next quarter's earnings?

Teladoc Health updated its FY20 earnings guidance on Wednesday, July, 29th. The company provided EPS guidance of ($1.45-1.36) for the period, compared to the Thomson Reuters consensus earnings per share estimate of ($0.97). The company issued revenue guidance of $980-995 million, compared to the consensus revenue estimate of $872.82 million.

What price target have analysts set for TDOC?

28 analysts have issued twelve-month price targets for Teladoc Health's shares. Their forecasts range from $80.00 to $282.00. On average, they anticipate Teladoc Health's share price to reach $214.57 in the next twelve months. This suggests a possible upside of 1.1% from the stock's current price.
View analysts' price targets for Teladoc Health.

Are investors shorting Teladoc Health?

Teladoc Health saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 15,830,000 shares, an increase of 14.8% from the August 31st total of 13,790,000 shares. Based on an average daily trading volume, of 3,710,000 shares, the short-interest ratio is presently 4.3 days.
View Teladoc Health's Short Interest.

Who are some of Teladoc Health's key competitors?

Some companies that are related to Teladoc Health include Becton, Dickinson and (BDX), Regeneron Pharmaceuticals (REGN), Humana (HUM), Vertex Pharmaceuticals (VRTX), Boston Scientific (BSX), Takeda Pharmaceutical (TAK), Edwards Lifesciences (EW), Lonza Group (LZAGY), Illumina (ILMN), Bayer (BAYRY), HCA Healthcare (HCA), Biogen (BIIB), Bayer (BAYN), Baxter International (BAX) and DexCom (DXCM).
View all competitors.

What other stocks do shareholders of Teladoc Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teladoc Health investors own include NVIDIA (NVDA), Tesla (TSLA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Square (SQ), Shopify (SHOP), Docusign (DOCU), salesforce.com (CRM), Paypal (PYPL) and Zoom Video Communications (ZM).

Who are Teladoc Health's key executives?

Teladoc Health's management team includes the following people:
  • Mr. Jason Nathanial Gorevic, CEO & Director (Age 48, Pay $1.2M)
  • Ms. Mala Murthy, Chief Financial Officer (Age 56, Pay $647.34k)
  • Mr. David William Sides, Chief Operating Officer (Age 49, Pay $927.41k)
  • Mr. Adam Christian Vandervoort, Chief Legal Officer & Sec. (Age 45, Pay $541k)
  • Ms. Stephany Verstraete, Chief Marketing Officer (Age 51, Pay $503.37k)

When did Teladoc Health IPO?

(TDOC) raised $112 million in an IPO on Wednesday, July 1st 2015. The company issued 7,000,000 shares at $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities served as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

What is Teladoc Health's stock symbol?

Teladoc Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "TDOC."

Who are Teladoc Health's major shareholders?

Teladoc Health's stock is owned by a variety of retail and institutional investors. Top institutional investors include Riverbridge Partners LLC (0.66%), Westwood Management Corp IL (0.32%), Peregrine Capital Management LLC (0.20%), Envestnet Asset Management Inc. (0.16%), Nissay Asset Management Corp Japan ADV (0.13%) and Scout Investments Inc. (0.11%). Company insiders that own Teladoc Health stock include Adam C Vandervoort, Andrew Turitz, David L Shedlarz, David William Sides, Gabriel R Cappucci, Jason N Gorevic, Kenneth H Paulus, Lewis Levy, Mala Murthy, Mark Hirschhorn, Michael Goldstein, Michelle Bucaria, Peter A Mcclennen, Stephany Verstraete and William H Frist.
View institutional ownership trends for Teladoc Health.

Which institutional investors are selling Teladoc Health stock?

TDOC stock was sold by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, Riverbridge Partners LLC, Westwood Management Corp IL, Spence Asset Management, Assenagon Asset Management S.A., Scout Investments Inc., Avitas Wealth Management LLC, and Landsberg Bennett & Dubbaneh LLC. Company insiders that have sold Teladoc Health company stock in the last year include Adam C Vandervoort, Andrew Turitz, David L Shedlarz, David William Sides, Gabriel R Cappucci, Jason N Gorevic, Kenneth H Paulus, Lewis Levy, Mala Murthy, Michael Goldstein, Michelle Bucaria, Stephany Verstraete, and William H Frist.
View insider buying and selling activity for Teladoc Health.

Which institutional investors are buying Teladoc Health stock?

TDOC stock was bought by a variety of institutional investors in the last quarter, including Jag Capital Management LLC, Envestnet Asset Management Inc., Sitrin Capital Management LLC, Nissay Asset Management Corp Japan ADV, Hall Laurie J Trustee, Steel Peak Wealth Management LLC, Lighthouse Financial Advisors Inc., and Avantax Advisory Services Inc..
View insider buying and selling activity for Teladoc Health.

How do I buy shares of Teladoc Health?

Shares of TDOC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Teladoc Health's stock price today?

One share of TDOC stock can currently be purchased for approximately $212.15.

How big of a company is Teladoc Health?

Teladoc Health has a market capitalization of $17.60 billion and generates $553.31 million in revenue each year. The health services provider earns $-98,860,000.00 in net income (profit) each year or ($1.49) on an earnings per share basis. Teladoc Health employs 2,400 workers across the globe.

What is Teladoc Health's official website?

The official website for Teladoc Health is www.teladochealth.com.

How can I contact Teladoc Health?

Teladoc Health's mailing address is 2 MANHATTANVILLE ROAD SUITE 203, PURCHASE NY, 10577. The health services provider can be reached via phone at 203-635-2002 or via email at [email protected]

This page was last updated on 10/26/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.